128 related articles for article (PubMed ID: 6431589)
1. [Total hemolytic complement, C3 and C3 convertase levels in cardiac and indeterminate forms of Chagas' disease].
Shikanai-Yasuda MA; Souza ZT; Yasuda PH; Baueb S; Castilho EA; Irulegui I; Vaz CA
Rev Inst Med Trop Sao Paulo; 1984; 26(1):13-8. PubMed ID: 6431589
[No Abstract] [Full Text] [Related]
2. Conversion of the C3 component of complement in mice infected with Trypanosoma cruzi.
Irulegui I; Chaves J; Ferri RG; de Souza ZW; de Souza HB; Castilho EA
Rev Inst Med Trop Sao Paulo; 1980; 22(2):62-8. PubMed ID: 6776614
[No Abstract] [Full Text] [Related]
3. Complement factors and acute phase reactants in the Guillain-Barré syndrome.
Tönnessen TI; Nyland H; Aarli JA
Eur Neurol; 1982; 21(2):124-8. PubMed ID: 6920298
[TBL] [Abstract][Full Text] [Related]
4. C3-activator and serum immunoglobulin levels in the midwestern Nigerian.
Wemambu SN
Public Health; 1984 Jul; 98(4):233-7. PubMed ID: 6435150
[No Abstract] [Full Text] [Related]
5. [Protein chemistry of the complement system].
Nagasawa S
Tanpakushitsu Kakusan Koso; 1983 Jan; 28(1):18-44. PubMed ID: 6340167
[No Abstract] [Full Text] [Related]
6. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
7. [Behavior of complement factors and plasma proteins in burns].
Angela GC; Tosco A; Giannone R; Magliacani G; Raiteri E
Arch Sci Med (Torino); 1981; 138(1):63-92. PubMed ID: 6166276
[TBL] [Abstract][Full Text] [Related]
8. [Intranuclear alpha 1-antitrypsin in HBs-Ag-seronegative hepatitis B with PAS-negative globular hyaline bodies containing the complements components C4, C3, and C3-activator (author's transl)].
Storch W; Kunze P
Acta Histochem; 1982; 70(1):31-5. PubMed ID: 6179123
[TBL] [Abstract][Full Text] [Related]
9. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
[No Abstract] [Full Text] [Related]
10. [Proteases of the complement system].
Nagasawa S
Seikagaku; 1983; 55(1):27-35. PubMed ID: 6302184
[No Abstract] [Full Text] [Related]
11. The complement system and the inflammatory response in experimental Chagas' disease.
Irulegui I; Yamashiro EH; Castilho EA; de Brito T
Rev Inst Med Trop Sao Paulo; 1982; 24(6):349-52. PubMed ID: 6820705
[No Abstract] [Full Text] [Related]
12. Effect of intraocular lenses on complement levels in human serum.
Mondino BJ; Rao H
Acta Ophthalmol (Copenh); 1983 Feb; 61(1):76-84. PubMed ID: 6407275
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
Strunk RC; Giclas PC
J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706
[No Abstract] [Full Text] [Related]
14. [Study of some immune functions in cardiac patients undergoing an extra-corporeal circulation operation (author's transl)].
Ros A; Reverdy ME; Fleurette J; Mikaeloff P; Gery C
Pathol Biol (Paris); 1979 Mar; 27(3):135-41. PubMed ID: 382053
[No Abstract] [Full Text] [Related]
15. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
16. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
17. Serum complement component depression during acute adenovirus conjunctivitis.
Gupta AK; Sarin GS
Br J Ophthalmol; 1984 May; 68(5):350-2. PubMed ID: 6324850
[TBL] [Abstract][Full Text] [Related]
18. [Immunological aspects of arteriosclerotic peripheral arteriopathies].
Del Guercio R; Conti G; Balzano A; Coppola A; De Buono AF
Boll Soc Ital Cardiol; 1977; 22(4):499-509. PubMed ID: 309761
[No Abstract] [Full Text] [Related]
19. Structure and molecular genetics of complement proteins. An update.
Volanakis JE
Year Immunol; 1986; 2():164-76. PubMed ID: 3554821
[No Abstract] [Full Text] [Related]
20. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
